Fuse Vectors has raised $5.2 million of funding as it moves closer to commercialising its innovative new approach to ...
Mayo Clinic's Precision Mouse Engineering Core in Minnesota can construct gene-targeted vectors for mice to assist researchers.
The funding will accelerate the development of Fuse's technology platform and pipeline of novel gene therapies. With its ...
Looking forward, greater use of column chromatography technologies in vector manufacturing could facilitate the adoption of ...
As Rare Disease Day is commemorated on 28 February, experts discuss the barriers to gene therapy access for some rare ...
A study led by UMass Chan Medical School researchers has demonstrated that a gene therapy to correct a mutation that causes ...
In the phase 1/2 INSPIRE DUCHENNE trial, interim data showed an average microdystrophin expression of 110% among participants ...
Researchers from the NIHR Moorfields Biomedical Research Centre and University College London have found that gene therapy improved visual acuity and preserved retinal structure in young children with ...
Genethon, a pioneering gene therapy research organization created by the AFM-Telethon, marks Rare Disease Day February 28, ...